Inhibition of the c-fms proto-oncogene autocrine loop and tumor phenotype in glucocorticoid stimulated human breast carcinoma cells

Breast Cancer Research and Treatment

Volumn 129, Issue 2, 2011, Pages 411-419

  Toy, Eugene P ^a   Lamb, Tiffany ^d   Azodi, Masoud ^b   Roy, William J ^c   Woo, Ho Hyung ^d   Chambers, Setsuko K ^d  

^a UNIVERSITY OF ROCHESTER   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Credentialed by MD Anderson Physicians Network   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

Author keywords

Breast cancer; c fms; Glucocorticoids; Invasion; Proto oncogene

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; COLONY STIMULATING FACTOR RECEPTOR; DEXAMETHASONE; GLUCOCORTICOID; KI 20227; MESSENGER RNA; QUINOLONE DERIVATIVE; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ARTICLE; AUTOCRINE EFFECT; BREAST CARCINOMA; C FMS GENE; CANCER CELL CULTURE; CELL ADHESION; CELL INVASION; CELL MOTILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; INHIBITION KINETICS; MOLECULARLY TARGETED THERAPY; PARACRINE SIGNALING; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTO ONCOGENE; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION;

AUTOCRINE COMMUNICATION; BREAST NEOPLASMS; CARCINOMA; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLUCOCORTICOIDS; HUMANS; MACROPHAGE COLONY-STIMULATING FACTOR; NEOPLASM INVASIVENESS; OLIGONUCLEOTIDES, ANTISENSE; PHENOTYPE; PHENYLUREA COMPOUNDS; PROTEIN KINASE INHIBITORS; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR; RNA INTERFERENCE; THIAZOLES; TRANSFECTION;

EID: 80052615694     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-1247-7     Document Type: Article

References (39)

1. BM Kacinski KA Scata D Carter LD Yee E Sapi BL King SK Chambers MA Jones MH Pirro ER Stanley LR Rohrschneider 1991 FMS (CSF-1 receptor) and CSF-1 transcripts and protein are expressed by human breast carcinomas in vivo and in vitro Oncogene 6 941 952 1829808 1:CAS:528:DyaK3MXmsFejtbs%3D (Pubitemid 21924171)
2. MB Flick E Sapi PL Perrotta MG Maher R Halaban D Carter BM Kacinski 1997 Recognition of activated CSF-1 receptor in breast carcinomas by a tyrosine 723 phosphospecific antibody Oncogene 14 2553 2561 9191055 10.1038/sj.onc.1201092 1:CAS:528:DyaK2sXktFSiu74%3D (Pubitemid 27273517)
3. SM Scholl V Mosseri R Tang P Pouillart 1993 Expression of colony stimulating factor-1 and its receptor (the protein product of c-fms) in invasive breast tumor cells Ann NY Acad Sci 698 131 135 8279750 10.1111/j.1749-6632. 1993.tb17199.x 1:CAS:528:DyaK2cXhtVCiu74%3D (Pubitemid 24027633)
4. HM Kluger M Dolled-Filhart S Rodov BM Kacinski RL Camp DL Rimm 2004 Macrophage colony-stimulating factor-1 receptor expression is associated with poor outcome in breast cancer by large cohort tissue microarray analysis Clin Cancer Res 10 173 177 14734466 10.1158/1078-0432.CCR-0699-3 1:CAS:528: DC%2BD2cXkvF2nug%3D%3D (Pubitemid 38114176)
5. SM Scholl C Pallud F Beuvon K Hacene ER Stanley L Rohrschneider R Tang P Pouillart R Lidereau 1994 Anti-colony-stimulating factor-1 antibody staining in primary breast adenocarcinomas correlates with marked inflammatory cell infiltrates and prognosis J Natl Cancer Inst 86 120 126 8271294 10.1093/jnci/86.2.120 1:STN:280:DyaK2c%2Fps1Ciug%3D%3D (Pubitemid 24040150)
6. MG Maher E Sapi B Turner A Gumbs PL Perrotta D Carter BM Kacinski BG Haffty 1998 Prognostic significance of colony-stimulating factor receptor expression in ipsilateral breast cancer recurrence Clin Cancer Res 4 1851 1856 9717811 1:CAS:528:DyaK1cXls1Ghur0%3D (Pubitemid 28369167)
7. R Tang B Kacinski P Validire F Beuvon X Sastre P Benoit A De la Rochefordiere V Mosseri P Pouillart S Scholl 1990 Oncogene amplification correlates with dense lymphocyte infiltration in human breast cancers: a role for hematopoietic growth factor release by tumor cells? J Cell Biochem 44 189 198 1980125 10.1002/jcb.240440307 1:CAS:528:DyaK3MXlvFOhtw%3D%3D
8. RS McDermott L Deneux V Mosseri J Vedrenne K Clough A Fourquet J Rodriguez JM Cosset X Sastre Beuzeboc P Pouillart SM Scholl 2002 Circulating macrophage colony stimulating factor as a marker of tumour progression Eur Cytokine Netw 13 121 127 11956031 1:CAS:528:DC%2BD38Xkt1Smt7c%3D (Pubitemid 34535582)
9. E Sapi 2004 The role of CSF-1 in normal physiology of mammary gland and breast cancer: an update Exp Biol Med 229 1 1 11 1:CAS:528: DC%2BD2cXmsFKisQ%3D%3D (Pubitemid 38101673)
10. S Aharinejad P Paulus M Sioud M Hofmann K Zins R Schafer 2004 Colony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice Cancer Res 64 5378 5384 15289345 10.1158/0008-5472.CAN-04-0961 1:CAS:528:DC%2BD2cXmtF2mu78%3D (Pubitemid 39006559)
11. P Paulus ER Stanley R Schafer D Abraham S Aharinejad 2006 Colony-stimulating factor-1 antibody reverses chemoresistance in human MCF-7 breast cancer xenografts Cancer Res 66 4349 4356 16618760 10.1158/0008-5472.CAN- 05-3523 1:CAS:528:DC%2BD28XjsFSltbg%3D
12. EY Lin AV Nguyen RG Russell JW Pollard 2001 Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy J Exp Med 193 6 727 740 11257139 10.1084/jem.193.6.727 1:CAS:528:DC%2BD3MXitFKhsLo%3D (Pubitemid 32524466)
13. JW Pollard 2009 Trophic macrophages in development and disease Nat Rev Immunol 9 259 270 19282852 10.1038/nri2528 1:CAS:528:DC%2BD1MXjtFCisbc%3D
14. L Hernandez T Smirnova D Kedrin J Wyckoff L Zhu ER Stanley D Cox WJ Muller JW Pollard N Van Rooijen 2009 Segall JE (2009) The EGF/CSF-1 paracrine invasion loop can be triggered by Heregulin 1 and CXCL12 Cancer Res 69 3221 3227 19293185 10.1158/0008-5472.CAN-08-2871 1:CAS:528:DC%2BD1MXjvVWitLY%3D
15. S Goswami E Sahai JB Wyckoff M Cammer D Cox FJ Pixley ER Stanley JE Segall JS Condeelis 2005 Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop Cancer Res 65 5278 5283 15958574 10.1158/0008-5472.CAN-04-1853 1:CAS:528:DC%2BD2MXltFemu7k%3D (Pubitemid 40827339)
16. CN Wrobel J Debnath E Lin S Beausoleil MF Roussel JS Brugge 2004 Autocrine CSF-1R activation promotes Src-dependent disruption of mammary epithelial architecture J Cell Biol 165 2 263 273 15117969 10.1083/jcb.200309102 1:CAS:528:DC%2BD2cXjsFKrsr0%3D (Pubitemid 38544529)
17. AG Borycki F Smadja R Stanley SA Leibovitch 1995 Colony-stimulating factor 1 (CSF-1) is involved in an autocrine growth control of rat myogenic cells Exp Cell Res 218 213 222 7737360 10.1006/excr.1995.1149 1:CAS:528:DyaK2MXlsFShtrY%3D
18. E Sapi MB Flick S Rodov M Gilmore-Hebert M Kelley S Rockwell BM Kacinski 1996 Independent regulation of invasion and anchorage-independent growth by different autophosphorylation sites of the macrophage colony-stimulating factor 1 receptor Cancer Res 56 5704 5712 8971179 1:CAS:528:DyaK2sXjtFOk (Pubitemid 26422176)
19. RN Gunawardane DS Sgroi CN Wrobel E Koh GQ Daley JS Brugge 2005 Novel role for PDEF in epithelial cell migration and invasion Cancer Res 65 11572 11580 16357167 10.1158/0008-5472.CAN-05-1196 1:CAS:528:DC%2BD2MXhtlWiu73F (Pubitemid 41821716)
20. SK Chambers Y Wang RE Gertz BM Kacinski 1995 Macrophage colony-stimulating factor mediates invasion of ovarian cancer cells through urokinase Cancer Res 55 1578 1585 7882368 1:CAS:528:DyaK2MXkslWitrY%3D
21. AE Filderman A Bruckner BM Kacinski N Deng HG Remold 1992 Macrophage colony-stimulating factor (CSF-1) enhances invasiveness in CSF-1 receptor-positive carcinoma cell lines Cancer Res 52 3661 3666 1535551 1:CAS:528:DyaK38XkvVOkt7k%3D
22. EP Toy N Bonafe A Savlu C Zeiss W Zheng M Flick SK Chambers 2005 Correlation of tumor phenotype with c-fms proto-oncogene expression in an in vivo intraperitoneal model for experimental human breast cancer metastasis Clin Exp Metastasis 22 1 1 9 16132573 10.1007/s10585-005-0718-4 1:CAS:528: DC%2BD2MXhtFegtrfI (Pubitemid 41185856)
23. SK Das ER Stanley LJ Guilbert LW Forman 1981 Human colony-stimulating factor (CSF-1) radioimmunoassay: resolution of three subclasses of human colony-stimulating factors Blood 58 630 641 6973347 1:STN:280: DyaL3M3ls1SitA%3D%3D (Pubitemid 11002769)
24. A Patsialou J Wyckoff Y Wang S Goswami ER Stanley JS Condeelis 2009 Invasion of human breast cancer cells in vivo requires both paracrine and autocrine loops involving the colony-stimulating factor-1 receptor Cancer Res 69 9498 9506 19934330 10.1158/0008-5472.CAN-09-1868 1:CAS:528:DC%2BD1MXhsFGrtbfM
25. E Sapi MB Flick M Gilmore-Hebert S Rodov BM Kacinski 1995 Transcriptional regulation of the c-fms (CSF-1R) proto-oncogene in human breast carcinoma cells by glucocorticoids Oncogene 10 529 542 7845678 1:CAS:528:DyaK2MXjsl2mtLc%3D
26. SK Chambers Y Wang M Gilmore-Hebert BM Kacinski 1994 Post-transcriptional regulation of c-fms proto-oncogene expression by dexamethasone and of CSF-1 in human breast carcinomas in vitro Steroids 59 514 522 7846733 10.1016/0039-128X(94)90069-8 1:CAS:528:DyaK2cXlvFKhurg%3D (Pubitemid 24286765)
27. BM Kacinski MB Flick E Sapi 2001 RU-486 can abolish glucocorticoid- induced increases in CSF-1 receptor expression in primary human breast carcinoma specimens J Soc Gynecol Investig 8 114 116 11336883 10.1016/S1071-5576(01) 00092-2 1:CAS:528:DC%2BD3MXjtFGgs74%3D (Pubitemid 32385405)
28. S Wei S Nandi V Chitu YG Yeung W Yu M Huang LT Williams H Lin ER Stanley 2010 Functional overlap but differential expression of CSF-1 and IL-34 in their CSF-1 receptor-mediated regulation of myeloid cells J Leukoc Biol 88 495 505 20504948 10.1189/jlb.1209822 1:CAS:528:DC%2BC3cXhtFertrbN
29. W Wiktor-Jedrzejczak A Bartocci AW Ferrante Jr A Ahmed-Ansari KW Sell JW Pollard ER Stanley 1990 Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse Proc Natl Acad Sci USA 87 4828 4832 2191302 10.1073/pnas.87.12.4828 1:CAS:528:DyaK3cXksFOhsbg%3D (Pubitemid 20204197)
30. EP Toy M Azodi NL Folk CM Zito CJ Zeiss SK Chambers 2009 Enhanced ovarian cancer tumorigenesis and metastasis by the macrophage colony-stimulating factor (CSF-1) Neoplasia 11 2 136 144 19177198 1:CAS:528:DC%2BD1MXhvVOls7s%3D
31. H Ohno K Kubo H Murooka Y Kobayashi T Nishitoba M Shibuya T Yoneda T Isoe 2006 A c-fms tyrosine kinase inhibitor, Ki20227, suppresses osteoclast differentiation and osteolytic bone destruction in a bone metastasis model Mol Cancer Ther 5 11 2634 2643 17121910 10.1158/1535-7163.MCT-05-0313 1:CAS:528:DC%2BD28Xht1els7jF (Pubitemid 44848990)
32. T Hiraga H Nakamura 2009 Imatinib mesylate suppresses bone metastases of breast cancer by inhibiting osteoclasts through the blockade of c-Fms signals Int J Cancer 124 215 222 18814279 10.1002/ijc.23903 1:CAS:528:DC%2BD1cXhsFahtrbK
33. Chambers SK (2000) In vitro invasion assays. In: Bartlett J (ed) Methods in molecular medicine: ovarian cancer. Humana Press Inc., Totowa, NJ, pp 179-185
34. SK Chambers CM Ivins BM Kacinski RB Hochberg 2004 An unexpected effect of glucocorticoids on stimulation of c-fms proto-oncogene expression in choriocarcinoma cells expressing little glucocorticoid receptor Am J Obstet Gynecol 190 974 985 15118624 10.1016/j.ajog.2004.01.021 1:CAS:528: DC%2BD2cXkvVGltbw%3D (Pubitemid 38561512)
35. SK Chambers M Gilmore-Hebert Y Wang S Rodov EJ Benz BM Kacinski 1993 Post-transcriptional regulation of CSF-1 and CSF-1 receptor gene expression during inhibition of phorbol-ester induced monocytic differentiation by dexamethasone and cyclosporin A: potential involvement of a destabilizing protein Exp Hematol 21 1328 1334 8359233 1:CAS:528:DyaK2cXis1aisbk%3D (Pubitemid 24222996)
36. HH Woo Y Zhou X Yi CL David W Zheng M Gilmore-Hebert HM Kluger EC Ulukus T Baker JB Stoffer SK Chambers 2009 Regulation of non AU-rich element containing c-fms proto-oncogene expression by HuR in breast cancer Oncogene 28 9 1176 1186 19151756 10.1038/onc.2008.469 1:CAS:528:DC%2BD1MXktVOktro%3D
37. Woo HH, Yi X, Lamb T, Menzl I, Baker T, Shapiro DJ, Chambers SK (2010) Post-transcriptional suppression of proto-oncogene c-fms expression by vigilin in breast cancer. Mol Cell Biol. doi: 10.1128/MCB.01031-10
38. P Lorinz T Misteli BF Baker CF Bennett DL Spector 2000 Nucleocytoplasmic shuttling: a novel in vivo property of antisense phosphorothioate oligodeoxynucleotides Nucleic Acids Res 28 2 582 10.1093/nar/28.2.582
39. W Yang M Saad RI Pakunlu JJ Khandare OB Garbuzenko AA Vetcher VA Soldatenkov VP Pozharov T Minko 2008 Nonviral nanoscale-based delivery of antisense oligonucleotides targeted to hypoxia-inducible factor 1α enhances the efficacy of chemotherapy in drug-resistant tumor Clin Cancer Res 14 11 3607 3616 10.1158/1078-0432.CCR-07-2020